Back

ATP9A in erythrocytes: a regulator of extracellular vesicle release and endothelial dysfunction in type 2 diabetes

17 April 2026 (16:10 - 17:10)
Organised by: Logo
Congress Presentation Part of: Extracellular vesicles and nanoparticles in vascular disease Microvesicles, Exosomes Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Mrs Rawan Humoud

Karolinska Institute, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail
Role of extracellular vesicles in endothelial activation and ascending aortic aneurysm development
Doctor C. Reyes Goya (Stockholm, SE)
Abstract
Presentation thumbnail
Circulating extracellular vesicles as mediators of NETosis in pulmonary arterial hypertension
Assistant Professor A. Khandagale (Uppsala, SE)
Abstract
Presentation thumbnail
Myeloperoxidase delivered by erythrocyte-derived extracellular vesicles promotes oxidative stress and endothelial dysfunction in type 2 diabetes
Doctor A. Collado (Stockholm, SE)
Abstract
Presentation thumbnail
Extracellular vesicle-mediated transfer of red blood cell non-coding RNAs induces vascular endothelial dysfunction in type 2 diabetes
Miss E. Kontidou (Stockholm, SE)
Abstract
Presentation thumbnail
Red blood cells and their extracellular vesicles drive vascular endothelial dysfunction in type 2 diabetes through vascular VEGFR2
Associate Professor Z. Zhou (Stockholm, SE)
Abstract

Access the full session

Session thumbnail
Extracellular vesicles and nanoparticles in vascular disease

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

17 April 2026 16:10 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources